EFISHient Protein Announces Successful Development of Tilapia Cell Line
EFISHient Protein, at the forefront of FoodTech innovation, achieves a breakthrough in Tilapia cell line development, revolutionizing the landscape of cultivated meat technology and driving sustainable fish production forward.
Through cutting-edge technological capabilities, EFISHient Protein has unlocked the potential to produce muscle and fat cells of Tilapia, a key step towards establishing a genetic cell bank. This milestone underscores EFISHient Protein's commitment to providing alternative protein solutions and promoting sustainable practices in the global fish products industry.
EFISHient Protein's partnership with BioMeat Foodtech and the Volcani Institute has been instrumental in combining breakthrough technology with extensive experience in the alternative protein sector. This collaboration positions EFISHient Protein as a promising player in the cultivated fish industry, poised to deliver affordable and environmentally responsible products worldwide.
As a business-to-business (B2B) company, EFISHient Protein is actively engaging with major fish product manufacturers globally. The company's goal is to scale up production and make their technology accessible at competitive prices, contributing to global food security while preserving marine ecosystems.
About EFISHient Protein:
EFISHient Protein is a leading Israeli B2B FoodTech company that is dedicated to accelerating sustainable whitefish meat production efficiently. They aim to provide nutritious, delicious, ethical, and affordable solutions that can be enjoyed by everyone.
Leveraging their unique expertise in white fish science along with alternative protein industry know-how, EFISHient Protein develops a pioneering cultivated whitefish meat production system. This system is designed to be utilized by food manufacturers and food service industries across the globe, revolutionizing the way white fish meat is produced and consumed.
Photo: https://mma.prnewswire.com/media/2381451/EFISHient_Protein.jpg
For media inquiries or further information, please contact
View original content to download multimedia:https://www.prnewswire.com/news-releases/efishient-protein-announces-successful-development-of-tilapia-cell-line-302111384.html
SOURCE EFISHient Protein
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Southern Company announces upsize and pricing of $725 million in aggregate principal amount of Series 2026A 2.125% Convertible Senior Notes due December 15, 2027 and $1.65 billion in aggregate princip
- Rockford Fosgate® Expands Polaris Audio Lineup with New RZR and Sportsman Systems
- ArtArch Merges All Products into Unified Platform, Elevates Positioning to "AI-Native Creative OS"
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share